血缘供者造血干细胞移植后患者上消化道移植物抗宿主病临床特征及小剂量激素疗效分析
被引量:3
摘要
移植物抗宿主病(GVHD)是异基因造血干细胞移植(allo—HSCT)的主要并发症之一,直接影响移植疗效。1985年Snover等识别出一种发生于aIlo—HSCT后早期的上消化道综合征,临床表现为恶心、呕吐、食欲减退、不能进食,命名为上消化道GVHD,其中一部分患者可进展为典型的胃肠道GVHD。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2011年第2期118-120,共3页
Chinese Journal of Hematology
参考文献8
-
1Snover DC,Weisdorf SA,Vercellotti GM,et al.A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation.Hum Pathol,1985,16:387-392. 被引量:1
-
2Wu D,Poncc RJ,Brentnall T,et al.Causes of nausea and anorexia in marrow transplant patients:a prospective study.Gastroenterology,1995,108 (Suppl):A945. 被引量:1
-
3Wakui M,Okamoto S,Ishida A,et al.Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.Bone Marrow Transplant,1999,23:573-578. 被引量:1
-
4Varadarajan P,Dunford LM,Thomas JA,et al.Seeing what's out of sight:wireless capsule endoscopy's unique ability to visualazie and accurately assess the severity of gastrointestinal graft-versushost disease.Biol Blood Marrow Transplant,2009,15:643-648. 被引量:1
-
5王莉红,任汉云,李渊,邱志祥,岑溪南,欧晋平,许蔚林,王茫桔,王颖,董玉君.HLA相合同胞和不全相合血缘关系供者造血干细胞移植的临床对比研究[J].中华血液学杂志,2008,29(8):507-511. 被引量:10
-
6Glucksberg H,Storb R,Fefer A,et al.Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors.Transplantation,1974,19:295-304. 被引量:1
-
7Washington K,Bentley RC,Green A.Gastric graft-versus-host disease:a blinded histologic study.Am J Surg Pathol,1997,21:1037-1046. 被引量:1
-
8Weisdorf DJ,Snover DC,Haake R,et al.Acute upper gastrointestinal graft-versus-host disease:clinical significance and response to immunosuppressive therapy.Blood,1990,76:624-629. 被引量:1
二级参考文献10
-
1Gluckberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA- matched sibling donors. Transplantation, 1974,18 : 295-304. 被引量:1
-
2Petersdorf EW. Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol, 2007, 20:155-170. 被引量:1
-
3Basara N, Baurmann H, Kolbe K, et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: resuits from the multicenter German Cooperative Study Group. Bone Marrow Transplant, 2005, 35:1011-1018. 被引量:1
-
4Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood, 2006,107:3065-3073. 被引量:1
-
5Kroger N, Zabelina T, Kruger W, et al. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Br J Haematol, 2001,113 : 1060-1071. 被引量:1
-
6Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood, 1999, 94:2208-2216. 被引量:1
-
7Yamasaki S, Ohno Y, Taniguchi S, et al. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies. Bone Marrow Transplant, 2004,33:279-289. 被引量:1
-
8Hasegawa W, Lipton JH, Messner HA, et al. Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. Hematology, 2003, 8 : 27 -33. 被引量:1
-
9Nachbaur D, Eibl B, Kropshofer G,et al. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res, 2002,11:731-737. 被引量:1
-
10Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol, 1997,15 : 1767-1777. 被引量:1
共引文献9
-
1王莉红,任汉云,孙玉华,邱志祥,岑溪南,欧晋平,许蔚林,王茫桔,王文生,李渊,董玉君,尹玥,梁赜隐.造血干细胞移植后单个核细胞EBV—DNA定量监测预测移植后淋巴增殖性疾病[J].中华血液学杂志,2010,31(2):73-76. 被引量:3
-
2宋建君,任汉云,邱志祥,王茫桔,许蔚林,刘微,李渊,董玉君,尹玥,孙玉华,王莉红,欧晋平,王文生,岑溪南.造血干细胞移植受者慢性疾病状态及相关因素研究[J].中华血液学杂志,2012,33(8):615-618. 被引量:1
-
3黄花荣,张娜,孔倩.造血干细胞移植患者早期发生呼吸道感染的危险因素分析[J].中国病理生理杂志,2012,28(8):1466-1470. 被引量:1
-
4张永清,施兵,刘丽辉,冯凯,叶丽萍,田登梅,胡文青,何圣科,冯超,石炳毅.亲缘单倍体供者与非血缘相合供者造血干细胞移植的临床疗效研究[J].中华细胞与干细胞杂志(电子版),2015,5(2):14-18. 被引量:3
-
5张永清,刘丽辉,施兵,冯凯,叶丽萍,田登梅,胡文青,何圣科,石炳毅.亲缘HLA单倍体半相合造血干细胞移植对高危或难治性急性白血病的临床疗效与安全性[J].中华细胞与干细胞杂志(电子版),2015,5(2):24-27.
-
6叶珂,廖明燕,唐晓琼,王利,张红宾,肖青,刘林.造血干细胞移植治疗急性髓系白血病40例临床观察[J].现代医药卫生,2016,32(7):986-989. 被引量:1
-
7张巧,刘林,廖明燕,唐晓琼,王利,张红宾,肖青.配型相合同胞供者与单倍体相合造血干细胞移植治疗恶性血液病的单中心临床研究[J].国际输血及血液学杂志,2016,39(3):191-199. 被引量:7
-
8王莉红,邱志祥,李渊,董玉君,欧晋平,刘微,许蔚林,王茫桔,孙玉华,尹玥,王倩,梁赜隐,王文生,岑溪南,任汉云.采用白消安联合增量氟达拉滨预处理的allo-HSCT治疗中高危髓系白血病111例[J].中华器官移植杂志,2016,37(5):263-266. 被引量:6
-
9高欣宝,温树鹏,邢丽娜,牛志云,王颖,王福旭,张学军.单倍型相合造血干细胞移植治疗恶性血液病与人类白细胞抗原相合同胞移植疗效相当[J].临床荟萃,2017,32(8):665-671. 被引量:1
同被引文献40
-
1王征,樊嘉.雷帕霉素在器官移植中的研究进展[J].国外医学(移植与血液净化分册),2004,2(5):33-35. 被引量:5
-
2黄科,黎阳,黄绍良,方建培,周敦华,陈纯.慢性移植物抗宿主病的预防和治疗[J].中华儿科杂志,2005,43(3):174-177. 被引量:2
-
3林凤茹,姚尔固.雷帕霉素在血液病中的应用[J].国际输血及血液学杂志,2006,29(3):266-269. 被引量:7
-
4杨凯,刘启发,范志平,孙竞,徐丹,魏永强,张钰,孟凡义.血缘与非血缘供者异基因造血干细胞移植治疗白血病的比较研究[J].中华内科杂志,2007,46(2):135-139. 被引量:3
-
5Das R,Chen X, Komorowski R, et al. Interleukin-23 secretion by donor antigen presenting ceils is critical for organ-specific pathology in graft versus-host disease [ J ]. Blood, 2009, 113 (10) : 2352-2362. 被引量:1
-
6Vogelsang GB,Wagner JE. Graft-versus-host disease[J]. Hematol Oncol Clin North Am, 1990, 4 (3) : 625-639. 被引量:1
-
7A1-Ghamdi H, Leisenring W, Bensinger WI, et al. A proposed objective way to assess results of randomized prospective clini- cal trials with acute graft-versus-host disease as an outcome of interest[J]. Br J Haematol,2001,113(2) :461-469. 被引量:1
-
8da Gama Torres HO,Vilela EG,da Cunha AS,et al. Efficacy of glutamine-supplemented parenteral nutrition on short-term survival following allo-SCT: a randomized study[J]. Bone Mar- row Transplant,2008,41 (12) :1021-1027. 被引量:1
-
9Villanueva FN, Perez-Simon JA, Silva FF, et al. Oral becometha- sone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease[J], giol Blood Marrow Transplant, 2009,15(10) :1331-1336. 被引量:1
-
10Andree H, Hilgendorf I, I.eithaeuser M, et al. Enteral budes onide in treatment for mild and moderate gastrointestinal chro nic GVHD [J]. Bone Marrow Transplant, 2008, 42 (8) 541-546. 被引量:1
引证文献3
-
1姚霆,朴大勋.胃肠道移植物抗宿主病治疗的进展[J].肿瘤防治研究,2012,39(4):481-483.
-
2李旭东,何易,王东宁,胡元,王文文,张祥忠,林东军.雷帕霉素治疗难治性广泛性慢性移植物抗宿主病[J].中国组织工程研究,2013,17(18):3287-3294. 被引量:2
-
3黄传玉,栾松华,杨金玲,王红新.造血干细胞移植预处理期消化道出血的护理[J].中国妇幼健康研究,2017,28(S1):254-255.
二级引证文献2
-
1Kai Gao,Yan-song Wang,Ya-jiang Yuan,Zhang-hui Wan,Tian-chen Yao,Hai-hong Li,Pei-fu Tang,Xi-fan Mei.Neuroprotective effect of rapamycin on spinal cord injury via activation of the Wnt/β-catenin signaling pathway[J].Neural Regeneration Research,2015,10(6):951-957. 被引量:7
-
2黄小丽,王三斌,刘林.芦可替尼联合西罗莫司预防同胞全相合HSCT后aGVHD的临床研究[J].重庆医学,2018,47(30):3920-3922. 被引量:1
-
1邹虹霞.小剂量激素替代疗法对子宫和卵巢的影响分析[J].中国医药科学,2013,3(19):179-180.
-
2王建安,胡新央.改善微环境是提高干细胞移植疗效的重要途径[J].中华心血管病杂志,2009,37(8):673-675. 被引量:1
-
3王君艳,王晓明.护理干预对肿瘤患者行AIL细胞免疫治疗的影响[J].中国医药指南,2015,13(2):275-276.
-
4徐勇,陈迎珍,黄颂敏,樊均明,刘先蓉.干燥综合征并发周期性麻痹的诊断和治疗[J].泸州医学院学报,2001,24(4):307-308. 被引量:1
-
5黄筠瑜,黄颖芬,何雪明,李巧兰,陈见兴.小剂量激素治疗老年人带状疱疹的观察和护理[J].国际医药卫生导报,2005,11(20):78-79. 被引量:1
-
6王汉华.小剂量激素治疗亚急性重症肝炎倾向46例[J].实用临床医学(江西),2001,15(A04):22-24. 被引量:15
-
7刘超,丁训杰,谢毅,林果为,赵宁,于浩.影响自身骨髓移植疗效的COX多元回归分析[J].上海医科大学学报,1995,22(4):316-317.
-
8武倩,周芳.急性移植物抗宿主病的防治对提高单倍体造血干细胞移植疗效的进展[J].中华器官移植杂志,2015,36(12):759-763.
-
9王琴.舒利迭吸入治疗小儿哮喘的护理体会[J].护士进修杂志,2006,21(9):859-860. 被引量:1
-
10刘莎,郝文革,黄永兰,孙新.脐血总有核细胞数对脐血移植疗效的影响[J].中国当代儿科杂志,2010,12(7):551-556. 被引量:4